• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

510(k) Premarket Notification

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back To Search Results
Device Classification Name alzheimer’s disease pathology assessment test
510(k) Number K221842
Device Name Elecsys B-Amyloid (1-42) CSF II, Elecsys Phospho-Tau (181P) CSF
Roche Diagnostics
9115 Hague Rd.
Indianapolis,  IN  46250
Applicant Contact Greg Mondics
Roche Diagnostics
9115 Hague Rd.
Indianapolis,  IN  46250
Correspondent Contact Greg Mondics
Regulation Number866.5840
Classification Product Code
Date Received06/24/2022
Decision Date 12/07/2022
Decision Substantially Equivalent (SESE)
Regulation Medical Specialty Immunology
510k Review Panel Immunology
Summary Summary
FDA Review Decision Summary
Type Traditional
Reviewed by Third Party No
Combination Product No